u/Suitable-Support-965

PCCM fellow here.

I’ve noticed that a good number of consults (pleural effusion, lung nodules) that are found during an inpatient workup by IM teams lead to a lot of monetary benefit for the hospital.

(TPA/dornase for complex effusions, nodule biopsy, chemo infusions etc). That’s a lot of $$$ obviously.
I’m sure it’s the same for a lot of the cardiac, nephro, GI, rheum issues as well.

Any folks have come up with a way to capture these? I feel this is very important.

More than remuneration, it can help IM (and IM subspecialties like mine) demonstrate value and receive more institutional buy in during a time where other specialties seem to diminish the professional value of IM.

PCCM fellow here.

I’ve noticed that a good number of consults (pleural effusion, lung nodules) that are found during an inpatient workup by IM teams lead to a lot of monetary benefit for the hospital.

(TPA/dornase for complex effusions, nodule biopsy, chemo infusions etc). That’s a lot of $$$ obviously.
I’m sure it’s the same for a lot of the cardiac, nephro, GI, rheum issues as well.

Any folks have come up with a way to capture these? I feel this is very important.

More than remuneration, it can help IM (and IM subspecialties like mine) demonstrate value and receive more institutional buy in during a time where other specialties seem to diminish the professional value of IM.